Article
Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice.
The Journal of biological chemistry - 30 Dec 2005
Koldamova Radosveta, Staufenbiel Matthias, Lefterov Iliya
Abstract excerpt
ABCA1 (ATP-binding cassette transporter A1) is a major regulator of cholesterol efflux and high density lipoprotein (HDL) metabolism. Mutations in human ABCA1 cause severe HDL deficiencies characterized by the virtual absence of apoA-I and HDL and prevalent atherosclerosis. Recently, it has been reported that the lack of ABCA1 causes a significant reduction of apoE protein level in the brain of ABCA1 knock-out...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
